trending Market Intelligence /marketintelligence/en/news-insights/trending/0VWf1IZ-hS0uSmnEGPLZHw2 content esgSubNav
In This List

Kindred Biosciences raises additional $2.3M in offering

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


Kindred Biosciences raises additional $2.3M in offering

Kindred Biosciences Inc. said it closed the exercise of the underwriters' option to buy 314,000 shares, priced at $7.50 per share, as part of a public offering that initially closed July 17.

The company raised additional proceeds of about $2.3 million from the overallotment option, raising the offering's gross proceeds to about $24.8 million.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc., acted as sole book-running manager and Aegis Capital Corp. acted as lead manager.